Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ASNDAscendis Pharma A/SFY2025 · Dec |
|---|---|
| Revenue | $720.13M |
| Revenue, yoy | +98.0% |
| Net income | $228.03M |
| Net income, yoy | +39.7% |
| Net margin | -31.7% |
| Free cash flow | $469.80M |
| FCF margin | — |
| EPS, diluted | $3.76 |
Add another company.